Literature DB >> 32753705

Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation.

Jimin Shi1,2,3,4, Liqin Cao1,2,3,4, Yi Luo1,2,3,4, Yanmin Zhao1,2,3,4, Yamin Tan1,2,3,4, Jian Yu1,2,3,4, Xiaoyu Lai1,2,3,4, Yuanyuan Zhu1,2,3,4, Yongxian Hu1,2,3,4, Jingsong He1,2,3,4, Jie Sun1,2,3,4, Weiyan Zheng1,2,3,4, Guoqing Wei1,2,3,4, He Huang5,6,7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32753705     DOI： 10.1038/s41409-020-01015-w

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

1.  Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission.

Authors:  Andrew M Brunner; Shuli Li; Amir T Fathi; Martha Wadleigh; Vincent T Ho; Kerry Collier; Christine Connolly; Karen K Ballen; Corey S Cutler; Bimalangshu R Dey; Areej El-Jawahri; Sarah Nikiforow; Steven L McAfee; John Koreth; Daniel J Deangelo; Edwin P Alyea; Joseph H Antin; Thomas R Spitzer; Richard M Stone; Robert J Soiffer; Yi-Bin Chen
Journal:  Br J Haematol       Date:  2016-07-19       Impact factor: 6.998

2.  Frequency and prognostic impact of FLT3/ITD mutation in patients with acute myeloid leukaemia.

Authors:  N Govedarovic; G Marjanovic
Journal:  J BUON       Date:  2011 Jan-Mar       Impact factor: 2.533

3.  Sorafenib Maintenance Appears Safe and Improves Clinical Outcomes in FLT3-ITD Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Ahmad Antar; Mohamed A Kharfan-Dabaja; Rami Mahfouz; Ali Bazarbachi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-12-12

4.  Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study.

Authors:  Yu Wang; Dai-Hong Liu; Zhi-Ping Fan; Jing Sun; Xiao-Jin Wu; Xiao Ma; Lan-Ping Xu; Kai-Yan Liu; Qi-Fa Liu; De-Pei Wu; Xiao-Jun Huang
Journal:  Clin Transplant       Date:  2012-04-19       Impact factor: 2.863

Review 5.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

6.  Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival.

Authors:  Shawn Kothari; Andrew S Artz; Sang Mee Lee; Noreen Fulton; Jae-Hyun Park; Wendy Stock; Richard A Larson; Olatoyosi Odenike; Justin Kline; James LaBelle; Satyajit Kosuri; Peter Riedell; Yusuke Nakamura; Michael R Bishop; Hongtao Liu
Journal:  Bone Marrow Transplant       Date:  2020-01-28       Impact factor: 5.483
  6 in total
  4 in total

1.  Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation-A Systematic Review and Meta-Analysis.

Authors:  Jan Philipp Bewersdorf; Cecily Allen; Abu-Sayeef Mirza; Alyssa A Grimshaw; Smith Giri; Nikolai A Podoltsev; Lohith Gowda; Christina Cho; Martin S Tallman; Amer M Zeidan; Maximilian Stahl
Journal:  Transplant Cell Ther       Date:  2021-09-20

2.  TKI Maintenance After Stem-Cell Transplantation for FLT3-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Authors:  Nico Gagelmann; Christine Wolschke; Evgeny Klyuchnikov; Maximilian Christopeit; Francis Ayuk; Nicolaus Kröger
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

Review 3.  Optimization of Donor Lymphocyte Infusion for AML Relapse After Allo-HCT in the Era of New Drugs and Cell Engineering.

Authors:  Yishan Ye; Luxin Yang; Xiaolin Yuan; He Huang; Yi Luo
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

Review 4.  FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation.

Authors:  Francesca Biavasco; Robert Zeiser
Journal:  Int J Hematol       Date:  2022-04-23       Impact factor: 2.319
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.